Trial Profile
A retrospective, observational, multicentre, cohort trial will investigate the efficacy and safety boceprevir or telaprevir in combination with peginterferon and ribavirin in hepatitis C virus (HCV) genotype 1-infected veterans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2016 New trial record